Thursday, 27.08.2026
09:00 – 09:45
Registration
Welcome Desk
10:00 – 11:00
Plenary
Plenary 1
B Cells in Autoimmunity
11:00 – 11:30
Coffee Break
11:30 – 12:30
Plenary
Plenary 2
T Cells in Tolerance and Immunity
12:30 – 14:00
Lunch Break
13:00 – 13:45
Room 1
Industry Symposium 1
ALK-Abelló AG, Wallisellen
13:00 – 13:45
Room 3
Industry Symposium 2
Otsuka Pharmaceutical (Switzerland) GmbH, Glattbrugg
14:00 – 15:30
Room 1
SSAI-AILD Parallel Session 1
Granulomatous Disease: Focus on Sarcoidosis
14:00–14:18
Discussion after presentation: 5 minute(s)
Sarcoidosis: From a Pneumological Perspective
Katrin Hostettler Haack, Basel
14:23–14:41
Discussion after presentation: 5 minute(s)
Sarcoidosis: hepatological insights
Nasser Semmo, Bern
14:46–16:16
Discussion after presentation: 5 minute(s)
Sarcoidosis as a systemic disease – pitfalls and mimickers
Peter Korsten, Sendenhorst DE
16:21–16:39
Discussion after presentation: 5 minute(s)
Pathophysiology and actual treatment concepts in Macrophage activation syndrome / HLH
Klaus Tenbrock, Bern
14:00 – 15:30
Room 3
SSAI-AILD Parallel Session 2
Acteria Awardees Session on Immunology and Allergy
14:00 – 15:30
Room 4
SSAI-AILD Parallel Session 3
Clinical Immunology
14:00–14:25
Discussion after presentation: 5 minute(s)
ANCA-associated vasculitis: from autoantibodies to targeted treatments
Thomas Hauser, Zürich
14:30–14:55
Discussion after presentation: 5 minute(s)
Systemic lupus erythematosus: the role of B cells in pathogenesis and treatment
Camillo Ribi, Lausanne
15:00–15:25
Discussion after presentation: 5 minute(s)
IgG4-Related Disease: Pathophysiology, Diagnosis and Treatment
Jörg Seebach, Genève
14:00 – 15:30
Room 5
SSAI-AILD Parallel Session 4
New Levels of Immune Regulation
15:30 – 16:00
Coffee Break
16:00 – 17:30
Room 3
Hot Topics 1
Autoimmune Liver Disease
16:00–16:18
Discussion after presentation: 5 minute(s)
Liver Malignancy Risk in Autoimmune Liver Diseases: Pathogenesis and Clinical Implications
16:23–16:41
Discussion after presentation: 5 minute(s)
Variant Syndromes in 2026: New Insights and Evolving Concepts
16:46–17:04
Discussion after presentation: 5 minute(s)
IgG4-Related Disease: From Diagnostic Dilemmas to Emerging Opportunities
Yoh Zen, London GB
17:09–17:27
Discussion after presentation: 5 minute(s)
Clinical management and surveillance in daily practice in PSC
Ulrich Beuers, Amsterdam NL
17:30 – 17:45
Room Change
From 17:45
Plenary
Patients' Session
17:45–19:15
Discussion after presentation: 5 minute(s)
SwissHepa and patient organisation in Ticino
Claudia Rizzi, Locarno
18:15 – 19:00